Authors
Latest:
HPV Update: Making Sense of the New ACIP RecommendationsPreviously, vaccination was not recommended for patients in a certain age range, as there was no demonstrated benefit to HPV vaccination; however, this is about to change.
Latest:
Medication Management: A Team SportHow do we achieve optimal results for patients? This vision includes strategies and steps for a broader system of care based on the premise that health care professionals cannot go it alone.
Latest:
3 Findings on Colds You May Have MissedThree studies published last year provide useful information on risk factors for colds, which affect adults 2 to 3 times a year.
Latest:
Neuropathic PainNeuropathic pain is a chronic nerve pain that can significantly impair a patient's functioning and quality of life.
Latest:
A Call to Action for Evidence-based, Outcomes-driven Conflict Management StylesWith expanding pharmacy practice, it is time to explore conflict management, and its necessity in this current climate.
Latest:
Web Exclusive: Real-World Anti-TNF Dose Escalation in Patients With Crohn's DiseaseThis study evaluated the rates of dose escalation in patients with Crohn's disease.
Latest:
Clinical Insights: Palforzia is the First FDA-approved Treatment of Peanut AllergyPeanut allergies affect approximately 1.2% of the entire US population and an estimated 2.5% of the childhood population.
Latest:
Factors Associated With Employee Participation in a Value-Based Insurance Design InitiativeWe describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.
Latest:
Evaluation of Dual Versus Triple Therapy for Hepatitis CIn this retrospective chart review, patients with hepatitis C had a sustained virologic response with either dual or triple therapy.
Latest:
Psoriasis Treatment Cost Comparison: Biologics Versus Home PhototherapyAn estimation and comparison of the cost of home phototherapy versus biologics over a 3-year time horizon in patients with moderate-to-severe plaque psoriasis.
Latest:
340B Focus: Working With ConsultantsThe 340B Drug Pricing Program contains several complexities that covered entities are expected to govern and oversee.
Latest:
Claims Data Analysis of Dosing and Cost of TNF AntagonistHigher drug costs may be attributable to either high initial doses or a dose increase.
Latest:
Pharmacists: Attend a Non-Pharmacy ConferenceTaking advantage of all the value that nonpharmacy organizations have to offer.
Latest:
The Skinny on Weight-Loss MedicationsDespite the availability of such products, obesity continues to signifi- cantly contribute to morbidity and mortality in the United States.
Latest:
High-Touch Specialty Pharmacy Services Improve Migraine Medication Access and AffordabilityThe underlying purpose of a study presentation that won the Top Poster Award at the 2019 National Association of Specialty Pharmacy Annual Meeting and Expo in Washington, DC, was to assess whether high-touch, clinic-based specialty pharmacy services could positively affect the affordability of self- and provider-administered migraine medications for patients.
Latest:
Develop a Collaborative Pain Management StrategyA comprehensive approach requires that patients play an active role in determining medication and nonpharmacologic treatments.
Latest:
Child Health Care at Retail ClinicsPediatric health care in the retail clinic setting has been a hot-button issue since the walk-in clinic first entered into big-box stores and pharmacy retailers in the early 2000s.
Latest:
COVID-19 in the Classroom: Challenges and OpportunitiesFrom navigating online classes to adjusting to either cancelled or switched experiential learning rotations, the pandemic has changed the lives of pharmacy students worldwide.
Latest:
The Evolution of Specialty MedicineWith the groundbreaking advancements in specialty pharmacy, it is important to recognize the uniqueness of these medications and their respective patient populations.
Latest:
Study Shows Similar Efficacy, Safety of Humira BiosimilarAmgen’s ABP 501 (Amjevita) shows similar efficacy to the reference adalimumab (Humira) in treating rheumatoid arthritis and supported approval of the biosimilar by the FDA.
Latest:
Pharmacists In Position to Impact Change for Hepatitis CPresenters at the International Pharmaceutical Federation (FIP) World Congress in Glasgow, Scotland identified the current landscape of Hepatitis C, how pharmacists can position themselves to aid in point of care testing, and ways to better educate patients and providers.
Latest:
Enhancing the Strategy for Specialty PharmaceuticalsStrategies for controlling use of specialty pharmaceuticals should focus on situations where these agents are used inappropriately and on improvement of the complex billing process.
